US Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingUS Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement

Gates Foundation – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingGates Foundation – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:May 14, 2021
• Post category:

Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement

US Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement

• Post author:GHIAA Admin
• Post published:April 16, 2021
• Post category:

Continue ReadingUS Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement

BARDA – Moderna, COVID-19 Vaccine Development Agreement

• Post author:GHIAA Admin
• Post published:January 19, 2021
• Post category:

Continue ReadingBARDA – Moderna, COVID-19 Vaccine Development Agreement

NIH – Non-Profit, Model License Agreement Terms

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingNIH – Non-Profit, Model License Agreement Terms

IMI 2 Joint Undertaking Model Consortium Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingIMI 2 Joint Undertaking Model Consortium Agreement

IMI 2 Model Grant Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingIMI 2 Model Grant Agreement